ImmunityBio (NASDAQ: IBRX) director files insider report with no holdings

Rhea-AI Filing Summary

ImmunityBio, Inc. disclosed that one of its directors filed an initial insider ownership statement effective 12/12/2025, reporting no beneficial ownership of ImmunityBio securities.

The filing shows the director does not hold any shares or derivative securities of the company, was filed by a single reporting person, and was signed by /s/ Philip LoScalzo as attorney-in-fact.

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Wendel Bruce

(Last) (First) (Middle)

C/O IMMUNITYBIO, INC.

3530 JOHN HOPKINS COURT

(Street)

SAN DIEGO CA 92121

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
12/12/2025

3. Issuer Name and Ticker or Trading Symbol
ImmunityBio, Inc. [ IBRX ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

Exhibit 24 - Power of Attorney

No securities are beneficially owned.

	/s/ Philip LoScalzo, as Attorney-in-Fact	12/16/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What does the latest insider ownership filing for ImmunityBio (IBRX) report?

The filing reports that a director of ImmunityBio, Inc. currently has no beneficial ownership of the company’s securities, meaning they report holding no shares or derivative securities.

What is the event date referenced in this ImmunityBio (IBRX) insider report?

The insider ownership statement is effective as of 12/12/2025, which is listed as the Date of Event Requiring Statement.

What is the relationship of the reporting person to ImmunityBio (IBRX)?

The reporting person is identified as a Director of ImmunityBio, Inc., with that box checked under the relationship section of the report.

Does the ImmunityBio (IBRX) director report any derivative securities?

No. The remarks state “No securities are beneficially owned”, and the table for derivative securities shows no positions, indicating no reported options, warrants, or other derivatives.

Is this ImmunityBio (IBRX) insider report filed for one person or a group?

The filing indicates it is a Form filed by One Reporting Person, not a joint or group filing.

Who signed the ImmunityBio (IBRX) insider ownership statement?

The document is signed “/s/ Philip LoScalzo, as Attorney-in-Fact”, indicating it was executed under a power of attorney identified as Exhibit 24.